Bio-Techne Corporation

Bio-Techne Corporation annual/quarterly operating income history and growth rate from 2009 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.

• Bio-Techne Corporation operating income for the quarter ending March 31, 2026 was 75.5 M, a 95.04% increase year-over-year.
• Bio-Techne Corporation operating income for the twelve months ending March 31, 2026 was 216.3 M, a 12.43% increase year-over-year.
• Bio-Techne Corporation annual operating income for 2025 was 102.3 M, a 50.53% decrease from 2024.
• Bio-Techne Corporation annual operating income for 2024 was 206.7 M, a 30.86% decrease from 2023.
• Bio-Techne Corporation annual operating income for 2023 was 298.9 M, a 0.79% increase from 2022.
• Bio-Techne Corporation annual operating income for 2022 was 296.6 M.